Shares in rival vaccine makers Intercell ICEL

Jan 9 (Reuters) - Ukrainian domestic industrial gasconsumption has tumbled by about a third since Russia cut offsupplies, Naftogaz said on Friday. Stocks Russia The following are companies and utilities that have beenaffected: Zaporizhstal steel works ZPST.PFT has cut by half itsconsumption of gas, the local mayor's office said in astatement The steel firm did not answer requests for comment. Hot water and heating has been affected in some areas butit was not immediately clear whether gas deliveries fell becauseof the dispute with Russia or over long-standing local rows overunpaid bills. Temperatures fell to minus 8 degreesCelsius over night in the area. Russia's Black Sea fleet isstationed in Sevastopol under a lease agreement that has beenthe subject of heated debate between Moscow and Kiev.

Hot water in the town of Zhytomyr, about 100 km west ofKiev, has been cut. Ukraine's Ministry of Housing and Utilities said thatlocal heating and electricity providers had not been cut off butwere trying to reduce consumption to save gas. But a spokeswoman for the ministry said that unless thedispute was resolved by Monday, some gas cut-offs could takeplace "At the moment no-one has been cut off. If the question ofgas supplies cannot be resolved by Monday, then some utilitiesmay have to be cut off," said spokeswoman, Larysa Fedorchenko. Ukraine's largest chemical producer, the Odessa PortChemical Plant (OPZ), said it had completely stopped productiondue to reduced gas supplies OPZ is a major producer of ammoniaand fertilisers. The main heat and electricity producer for the capital,Kiev, said on Thursday it had started using fuel oil tocompensate for falling gas supplies, and residents reported adrop in temperature in their apartments. For a story on the impact on Ukraine's industy of the gascut click on ID:nL9215674 For more stories on the gas row, click on ID:nLV634765(Reporting by Pavel Polityuk, writing by Guy Faulconbridge;Editing by Dominic Evans) Stocks Russia.

In a country that's been built over years of racial divide, great strides have been taken in restoring the image locally and on the international stage.A country that respresents a multi-cultural, diverse group of people mending old wounds and striving for a better future.A nation where sports has united people from various race groups,religious backgrounds and cultural differences.After years of apartheid, division, disunity, disrespect for the lives of others...South Africa is now a country where it's citizens are proud to be a part of.Our sporting codes represent its people, our passion,commitment and dedication is why we haveachieved so much in the 15 or 16 years.But on Friday night in France, our countries image was butchered by the pathetic representation of ourNational Anthem.Ras Dumisani said to be born in Durban, South Africa now residing in France sang the Anthem with no tune, no keys and didn't have a n idea which word come next.In an International arena, the World Champs looks bemused, lost and some shocked by the rendition of not just an Anthem but the brick that cements this country.For people in South Africa, they accept the defeat andcongratulate the French on a well played game hard fought up front, but will not just accept an apology.The South African Rugby Assoc. has said that they take great care in selected the best individuals to render the National Anthems for any visiting nation, and sees torehearsals etc. LONDON (Reuters) - It promises to be a lousy year for many of Europe's cash-strapped biotechnology companies, but a lucky few stand to hit the jackpot in deals with 'Big Pharma'. DealsWyeth's WYE.N plan to scoop up Crucell (CRCL.AS) followed by unconfirmed reports of a possible counterbid by France's Sanofi-Aventis (SASY.PA) sent shares in the Dutch vaccine specialist soaring more than 40 percent on Thursday.Shares in rival vaccine makers Intercell (ICEL.VI) and Bavarian Nordic (BAVA.CO) also rose.Analysts and fund managers predict more such acquisitions in 2009, as large drugmakers look to biotech to refill product pipelines at a time when sales of old blockbusters are falling to generic competition.In contrast to many other sectors, large drugmakers enjoy relatively stable revenue and remain flush with cash despite the downturn.